ReviewClinical pharmacology and therapeutics2025

Utility of Biomarker-Informed Drug Interaction Evaluation in Drug Development and Regulatory Decision Making.

Akihiro Ishiguro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.